Leaders of Pharmaceutical Business Intelligence Group
| Leaders_of_Pharmaceutical_Business_Intelligence_logo.jpg | |
| File:Leaders of Pharmaceutical Business Intelligence logo.jpg | |
| Private | |
| ISIN | 🆔 |
| Industry | Life Sciences Tools & Services |
| Founded 📆 | 2012 |
| Founder 👔 | Aviva Lev-Ari |
Area served 🗺️ | |
Key people | Marcus Feldman, Stephen Williams, Joel Shertok |
| Members | |
Number of employees | |
| 🌐 Website | pharmaceuticalintelligence |
| 📇 Address | |
| 📞 telephone | |
Leaders in Pharmaceutical Business Intelligence Group (“LPBI Group”) is a leading, global venture performing pharmaceutical intelligence research, medical curations and life scientific reporting as a source that provides content to a wide range of thought leader audiences through the website pharmaceuticalintelligence.com.
The site covers three interrelated areas — an open-access online scientific journal, including a selection of timely podcasts and newsletters, a series of 18 BioMed e-books covering five specialties of medicine and a real-time press coverage of biotech, medical and life scientific global conferences.
The Group also synthesizes, analyzes and interprets therapeutic and disease information in various disciplines within biomedicine and life sciences through electronic publishing in the cloud with the goal of advancing knowledge and research efforts of the scientific and business community. The Group applies existing software algorithms, i.e., NLP, ML, AI on its own content for medical text analysis. The visualization results, as they develop are accompanied by domain knowledge expert interpretation of the medical text analysis outcomes. The existing content and the results of the Text analysis using Natural Language Processing are al in the process of migration to a blockchain IT Transactions network that will enable content monetization.
The Group, comprised of a highly experienced team in science, medicine and business. The Group was created in 2012 by Dr. Aviva Lev-Ari, Ph.D., R.N., and has contributing members in the US (MA, NJ, CA, PA, ME, DE), India, Israel and Canada.
This team reports on currently available medical and scientific information on a variety of subjects in the domains of BioMed, Biotech, MedTech, BioScience, Medicine, Pharmaceuticals, Life Sciences and Health care.
These subjects allow classification of all Journal articles under 700+ research categories forming the ontology of the Open Access Scientific Journal which benefits to date for a 2MM e-Reader crown and had published +7,500 scientific comments made by e-Readers to +6,000 articles of PharmaceuticalIntelligence.com.
The information explosion and its rapid obsolescence is a fact in electronic scientific publishing. The Group is actively responding to the scientific and business community with technologies and solutions that help advance the universe of health care research by using the methodology of curation for scientific findings from the perspective of clinical interpretations of the experimental results to effectively communicate the breakthrough in the interface of life sciences with medicine. [1]
Journal of Pharmaceutical Intelligence[edit]
LPBI reports on currently available medical and scientific information on a variety of subjects in the domains of BioMed, Biotech, MedTech, BioScience, Medicine, Pharmaceuticals, Life Sciences and Health care are followed by over 2 million readers. These subjects are classified under 700+ research categories forming the ontology of the Journal of PharmaceuticalIntelligence.com.
- Journal articles +6,000
- 18 e-Books in Medicine & Life Sciences on Amazon[2]
- Real-time press coverage of 100+ scientific conferences[3]
- 70 e-Proceedings and 36 Tweet collections
- Video & audio podcasts[4]
- 5,100 biological images with text legend
- 7,500+ comments from fellow scientists
Leadership[edit]
LPBI org chart LPBI's core group consists of:[5]
- Aviva Lev-Ari, PhD, RN, Founder, LPBI Group: 1.0 & 2.0
- Marcus Feldman, PhD, Member of the Board, Scientific Counsel: Life Sciences
- Stephen J. Williams, Member of the Board, Chief Scientific Officer, Senior Editor, PhD Pharmacology, BSc Toxicology
- Joel Shertok, PhD, Member of The Board, Business Development and Process Designer of a Global AI-based External Relations Prospecting System for LPBI Group
- Justin D. Pearlman, MD, PhD, FACC – Scientific Expert & Key Opinion Leader on Cardiovascular Diseases, Cardiac Imaging & Complex Diagnosis in Cardiology: Senior Editor & Author
- Sudipta Saha, PhD, Expert, Author, Writer, Co-Editor, Series D, Volume 2: Infectious Diseases
- Irina Robu, PhD – 3D BioPrinting, Tissue Engineering, Biomaterials, Nanotechnology & Drug Delivery
- Gail S. Thornton, PhD(c), Contributing Editor, Author and Medical Writer, Marketing Communications
- Ofer Markman, PhD – Advisor to LPBI Group’s Founder on the Biotech Ecosystem in Israel and Domain Expert on Text Analysis with ML
References[edit]
External links[edit]
This article "Leaders of Pharmaceutical Business Intelligence Group" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Leaders of Pharmaceutical Business Intelligence Group. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
